Subscribe
About us
Advertise with us
NeuroSens
Menu
Skip to content
Home
Neurology
Psychiatry
Topic: MS
Oral cladribine discontinued for MS
June 29, 2011
MS incidence higher in African Americans
April 15, 2011
Comorbidities common, delay MS diagnosis
April 15, 2011
Fingolimod: disease-free rates and effect on brain atrophy
April 15, 2011
MS patients may prefer new therapies regardless of risk
April 14, 2011
Alemtuzumab reduces 1-year sustained disability: CAMS223 analysis
April 14, 2011
Natalizumab discontinuation/interruption: relapse risk, poor tolerability
April 13, 2011
3-month disability progression reduced with fingolimod
April 13, 2011
B cell drug set to enter phase III testing
March 30, 2011
Dalfampridine may improve walking ability: phase III results
March 9, 2011
Previous
37
38
39
40
41
Next
